Institut Gustave Roussy

Site:	Institut Gustave Roussy			Go to their website
Address:
City:	Villejuif
State:	Val de Narne
Zip:	94805
Country:	France

35 trials at this site

Phase	Trial	Trial Status	Site Status [asc]	Drug	NCT#
2	Masitinib in Non Pre-treated, Inoperable Patients With Locally Advanced/Metastatic Gastro-intestinal Stromal Tumour (GIST)	Completed	Closed	Masitinib, (AB1010)	NCT00998751
2	A Study of R1507 in Patients With Recurrent or Refractory Sarcoma	Does not allow GIST	Closed	R1507	NCT00642941
2	Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors	Completed	Closed	Dasatinib (BMS-354825)	NCT00568750
2	A phase II study to compare efficacy and safety of masitinib at 12 mg/kg/day to sunitinib at 50 mg/day in treatment of patients with gastro-intestinal stromal tumor resistant to imatinib	Unknown	Closed	Masitinib, (AB1010)	NCT01506336
2	Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST) (PAZOGIST)	Completed	Closed	Pazopanib (Votrient)	NCT01323400
2	A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors	Ongoing, but not recruiting	Closed	MEK162 + BYL719	NCT01449058
2	Efficacy and Safety of PD-0332991 in Patients With Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib (CYCLIGIST)	Ongoing, but not recruiting	Closed	Palbociclib	NCT01907607
2	Ph II CABOGIST in GIST	Active, not recruiting	Closed	Cabozantinib	NCT02216578
1	Imatinib + IL-2	Ongoing, but not recruiting	Closed	Imatinib + IL-2
1	A Study Evaluating GDC-0980 Administered Once Weekly in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma	Ongoing, but not recruiting	Closed	GDC-0980	NCT00854126
1	Phase 1 dose-escalation study of oral tyrosine kinase inhibitor masitinib in advanced and/or metastatic solid cancers	Completed	Closed	Masitinib, (AB1010)
1	Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients	Ongoing, but not recruiting	Closed	BEZ235 + MEK162	NCT01337765
1	A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST Patients	Completed	Closed	Imatinib + BKM120	NCT01468688
1	(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors	Active, not recruiting	Closed	BLU-285	NCT02508532
2	Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial (PEMBROSARC)	Active, not recruiting	Not yet activated	Pembrolizumab + Cyclophosphamide	NCT02406781